The largest database of trusted experimental protocols

Spss version 23.0 statistical package

Manufactured by IBM
Sourced in United States

SPSS version 23.0 is a statistical software package developed by IBM. It provides a comprehensive set of tools for data analysis, including data management, statistical modeling, and reporting capabilities. The software is designed to help users efficiently analyze and interpret data from a wide range of sources.

Automatically generated - may contain errors

Lab products found in correlation

11 protocols using spss version 23.0 statistical package

1

Survival Analysis of Propensity-Matched Cohorts

Check if the same lab product or an alternative is used in the 5 most similar protocols
All statistical analyses and graphics were performed with the IBM SPSS version 23.0 statistical package (International Business Machines Corp., New Orchard Road Armonk, New York 10,504 914–499-1900, USA) for Windows. For comparisons of clinicopathologic characteristics between the two-propensity score-matched groups, the Chi-squared test or Fisher’s exact test were used for categorical variables as appropriate, and Student’s t-test was used for quantitative variables. Overall survival rates were determined using the Kaplan–Meier estimator, with an event being defined as death from cancer-related causes. The log-rank test was used to identify differences between the survival curves of different patient groups. In the univariate analysis, the 2-tailed Chi-square or 2-tailed t-test was used for statistical comparisons. In the multivariate analysis, Cox’s proportional hazard model was used to identify independent factors correlated with prognosis. The confidence interval (CI) method was used to compare differences in means between the predictive accuracy estimates for models that either included or did not include TDs. All p values were two-sided with p values < 0.05 considered statistically significant.
+ Open protocol
+ Expand
2

Evaluating Thyroid and Bone Metabolism Markers

Check if the same lab product or an alternative is used in the 5 most similar protocols
The level of serum T3 and T4 was determined with competitive chemiluminescent immunoassay (CLIA) kits, and the level of serum TSH was determined with ultra-sensitive sandwich CLIA with analyzer according to the manufacturer recommendation. Serum calcium levels were measured with ARSENAZO III system, serum phosphate levels were measured with ammonium molybdate system serum fluoride with ISE method, and serum alkaline phosphatase levels were measured with AMP buffer system. The collected data were tabulated and statistically analyzed. All the statistical operations were done through SPSS Version 23.0 statistical package (IBM corp., Washington DC, US). Data analysis was performed using paired t-test and repeated measures ANOVA.
+ Open protocol
+ Expand
3

Prevalence and Factors of Sleep Apnea

Check if the same lab product or an alternative is used in the 5 most similar protocols
The characteristics of the participants were described by using the means and standard deviations (SDs) for continuous variables and the frequencies and percentages for categorical variables. Comparison of categorical variables were determined using chi-square tests, and comparison of continuous variables were analyzed with two-tailed independent t tests.
The prevalence of SA was calculated by applying the SA index constructed with the use of previously defined criteria. To identify the factors associated with SA, variables were selected based on the strength of the associations. The odds ratio (OR) and 95% confidence intervals (CIs) were calculated; p ⩽ .05 were considered statistically significant. The Hosmer–Lemeshow test was used for testing the goodness of fit. Statistical analyses were conducted using SPSS version 23.0 statistical package (SPSS Inc., Chicago, IL, USA).
+ Open protocol
+ Expand
4

Statistical Analysis of Categorical and Continuous Variables

Check if the same lab product or an alternative is used in the 5 most similar protocols
Categorical variables were expressed as frequency and percentage and compared between groups using Chi-square or Fisher’s test when appropriate. The 95% confidence interval was also calculated. Continuous variables were expressed as mean ± standard deviation, with normal distributions verified by the Lilliefors test or Shapiro-Wilks test according the number of samples and tested by unpaired t test or Mann-Whitney U test, according to normality, and paired data by paired t test or Wilcoxon analysis. One-way ANOVA test or Kruskall-Wallis test according to normality were used to evaluate mean differences in 2 or more groups. Statistical significance was defined at P<0.05. All data were analyzed using the SPSS version. 23.0 statistical package (SPSS, Inc., Chicago, Illinois, USA).
+ Open protocol
+ Expand
5

Statistical Analysis of Continuous Data

Check if the same lab product or an alternative is used in the 5 most similar protocols
Normal distribution of continuous data was assessed using a one-sample Kolmogorov-Smirnov test. Normally distributed variables were reported as mean and standard deviation, whereas non-normally distributed variables were described as median and interquartile range (IQR). Pearson’s chi-square test or Fisher’s exact test were used to compare proportions between groups, as appropriate. The Student’s t-test and the Mann-Whitney U test were employed to determine the differences between normally distributed and non-normally distributed variables, respectively. A logistic regression analysis was performed to estimate the odds ratio (OR) and 95% confidence interval (95% CI) of the likelihood of zinc deficiency. A twosided P-value of less than 0.05 was considered statistically significant. Statistical analysis was performed using SPSS version 23.0 statistical package (SPSS, Chicago, IL, USA).
+ Open protocol
+ Expand
6

Student's t-test Statistical Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Data analyses were performed with Student's t-test between two groups. A p-value of <0.05 was considered statistically significant. All statistical analyses were conducted with SPSS version 23.0 statistical package (SPSS Inc., Chicago, IL, USA).
+ Open protocol
+ Expand
7

Temporal Trends in Statistical Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Data are presented as mean value ± standard deviation for continuous variables and proportions for categorical variables. The Cochran-Armitage trend test was used for analyzing temporal trends of categorical variables. The nonparametric test for trend by Jonckheere-Terpstra was used for continuous variables. All tests were two-tailed, with P < 0.05 considered significant. Statistical analyses were conducted with SAS version 9.4 (SAS Institute, Cary, NC, USA), R version 3.4.1, and SPSS version 23.0 statistical package (SPSS Inc., Chicago, IL, USA).
+ Open protocol
+ Expand
8

Statistical Analysis of Experimental Data

Check if the same lab product or an alternative is used in the 5 most similar protocols
The SPSS version 23.0 statistical package (SPSS Inc., Chicago, IL, USA) was used for statistical comparisons, and an independent statistician reviewed the results. Statistical significance was considered at p < 0.05.
Data were presented as descriptive statistics (mean and I.C.) using Tukey’s exploratory analysis. Adjustment to normality was determined using the Kolmogorov–Smirnov test, and between-group comparisons were performed using the Mann–Whitney U test and ANOVA test. The results were reviewed by an independent statistician (http://estadisticamurcia.com/web/#2).
+ Open protocol
+ Expand
9

Adherence to NOAC Dosing and Outcomes

Check if the same lab product or an alternative is used in the 5 most similar protocols
Continuous variables were presented as means and standard deviations. Comparison of continuous variables was performed using an independent t test or, in case of a non‐normal distribution, the Mann–Whitney test. Categorical variables were represented with numbers and percentages using the Chi‐square test of Fisher exact test. Incidence rates were estimated using the total number of study outcomes during the follow‐up period divided by person‐years at risk. The risk for clinical outcomes for study groups were obtained using survival analysis (Kaplan–Meier method and log‐rank test for univariate analysis and Cox proportional hazards regression for multivariate analysis). Cox proportional hazards regression was used to estimate the unadjusted and adjusted hazard ratio for the association between label adherence of NOAC dosing and clinical outcomes. To control for confounding, we added age, sex, chronic kidney disease, dyslipidemia, and other risk factors included in CHA2DS2‐VASc risk score factors (heart failure, hypertension, diabetes mellitus, stroke or transient ischemic attack, and vascular disease) to our multivariable models. Statistical significance was indicated by a P<0.05. All statistical analyses were performed using SAS version 9.4 (SAS Institute, Cary, NC) and SPSS version 23.0 statistical package (SPSS Inc., Chicago, IL, USA).
+ Open protocol
+ Expand
10

Serum Zinc Level Assessment

Check if the same lab product or an alternative is used in the 5 most similar protocols
A one-sample Kolmogorov–Smirnov test was used to assess whether the variables were normally distributed. Normally distributed variables were described as means and standard deviations; nonnormally distributed variables were presented as medians and interquartile ranges. The Pearson's Chi-square or Fisher's exact test was used to compare proportions between groups, as appropriate. The Student's t-test and Mann–Whitney U-test were used to verify the differences of normally distributed and nonnormally distributed variables, respectively. The change in serum zinc levels from baseline was assessed by a paired t-test and presented as mean and 95% confidence interval (CI). P < 0.05 was considered as statistically significant. Data were analyzed using SPSS version 23.0 statistical package (SPSS, Chicago, IL, USA).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!